Abridge | Latest News & Updates - Mar 14, 2025 Release
Abridge is collaborating with Mayo Clinic to enhance nursing workflows, as announced on March 11, 2025...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Abridge
🌎 abridge.comAbridge is a healthcare technology company founded in 2018 that specializes in transforming patient-clinician conversations into structured clinical notes using generative AI. Their platform enhances clinical documentation efficiency, allowing clinicians to focus on patient care while ensuring accurate and auditable AI-generated summaries. Abridge integrates deeply with electronic medical records (EMR) systems, setting industry standards for the responsible use of AI in healthcare.
Abridge - Latest News and Updates
- Abridge is collaborating with Mayo Clinic to enhance nursing workflows, as announced on March 11, 2025.
- Epic has partnered with Abridge, according to a Twitter post by Trey Lauderdale on March 9, 2025.
- Neal Smart has joined Abridge as Sr. Director, Enterprise Development, previously serving as Chief Revenue Officer at Health Note in the United States.
- Shiv Rao, founder and CEO of Abridge, participated in the K&L Gates-Carnegie Mellon University Conference on March 10-11 to discuss the ethics and governance of generative AI.
- Abridge optimized ML models for high throughput and built a flexible workflow orchestrator to scale LLM workflows.
- Shiv Rao, CEO of Abridge, participated in the CMU-K&L Gates Conference on Ethics and AI at Carnegie Mellon University.
- Endeavor Health is scaling its use of Abridge's AI-powered ambient documentation tool to reduce clinicians' administrative burden and improve patient care, according to Nadim Ilbawi, MD, physician director of innovation and care models at Endeavor Health.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.
